Intent to Understand the Meaning of Psychotic Symptoms During Patient-Psychiatrist Interactions.

Am J Psychother

Erikson Institute for Education, Research, and Advocacy, Austen Riggs Center, Stockbridge, Massachusetts (Ridenour); Department of Clinical Psychiatry, State University of New York Downstate Medical Center, and Psychoanalytic Association of New York, New York City (Garrett).

Published: February 2023

Research confirms that although patients experiencing psychosis want to speak about their symptoms with psychiatrists, psychiatrists are often hesitant to engage them directly in such conversations because of their fear of colluding, promoting defensiveness, or rupturing the therapeutic alliance. As a result, patients are often left to contend with confusing psychotic experiences, such as hallucinations and delusions, that they cannot make sense of on their own. In this article, the common barriers that prevent engagement in conversations about psychosis are described, and the conventional wisdom about the futility of talking with patients about delusions is challenged. The article suggests that instead of avoiding conversations about psychotic ideas, psychiatrists should embrace an "intent to understand," an inquisitive state of mind even in the face of seemingly incomprehensible symptoms. Such a stance can promote the therapeutic alliance, deepen an understanding of the patient as a person, and facilitate an integrative recovery style. Finally, the article offers clinical pointers, including the importance of behaving courteously and respectfully, listening to the affect expressed in the symptom, and looking for connections between the symptom and painful life experiences. Maintaining an intent to understand may help psychiatric residents-in-training, as well as experienced clinicians, to foster an empathic understanding that builds a positive therapeutic alliance and contributes to more successful pharmacotherapy and psychotherapeutic interventions.

Download full-text PDF

Source
http://dx.doi.org/10.1176/appi.psychotherapy.20220034DOI Listing

Publication Analysis

Top Keywords

therapeutic alliance
12
intent understand
8
understand meaning
4
meaning psychotic
4
psychotic symptoms
4
symptoms patient-psychiatrist
4
patient-psychiatrist interactions
4
interactions confirms
4
confirms patients
4
patients experiencing
4

Similar Publications

CD226 plays a vital role in natural killer (NK) cell cytotoxicity, interacting with its ligands CD112 and CD155 to initiate immune synapse formation, primarily through leukocyte function-associated-1 (LFA-1). Our study examined the role of CD226 in NK cell surveillance of acute myeloid leukemia (AML). NK cells in patients with AML had lower expression of CD226.

View Article and Find Full Text PDF

Background: Increasing one's walking speed is an important goal in post-stroke gait rehabilitation. Insufficient arm swing in people post-stroke might limit their ability to propel the body forward and increase walking speed.

Purpose: To investigate the speed-dependent changes (and their contributing factors) in the arm swing of persons post-stroke.

View Article and Find Full Text PDF

Background: Migraine is a disabling disorder that impacts 40 million people in the US. Zavegepant is the first calcitonin gene-related peptide (CGRP) receptor antagonist nasal-spray approved for the acute treatment of migraine with or without aura in adults. This study aimed to evaluate the proportion of patients in various pain and functional disability states over 48-h, for patients treated with zavegepant 10 mg nasal-spray versus placebo.

View Article and Find Full Text PDF

GT103 is a first-in-class, fully human, IgG3 monoclonal antibody targeting complement factor H that kills tumor cells and promotes anti-cancer immunity in preclinical models. We conducted a first-in-human phase 1b study dose escalation trial of GT103 in refractory non-small cell lung cancer to assess the safety of GT103 (NCT04314089). Dose escalation was performed using a "3 + 3" schema with primary objectives of determining safety, tolerability, PK profile and maximum tolerated dose (MTD) of GT103.

View Article and Find Full Text PDF

Enterocyte-like differentiation defines metabolic gene signatures of CMS3 colorectal cancers and provides therapeutic vulnerability.

Nat Commun

January 2025

Laboratory for Experimental Oncology and Radiobiology, Center for Experimental and Molecular Medicine, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.

Colorectal cancer (CRC) is stratified into four consensus molecular subtypes (CMS1-4). CMS3 represents the metabolic subtype, but its wiring remains largely undefined. To identify the underlying tumorigenesis of CMS3, organoids derived from 16 genetically engineered mouse models are analyzed.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!